Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Dicker

Showing results (1-10 of 286) with videos related to

Pageof 29
Sort By:
American Journal of Clinical Oncology|August 7, 2003
COX-2 inhibitors and cancer therapeutics: potential roles for inhibitors of COX-2 in combination with cytotoxic therapy: reports from a symposium held in conjunction with the Radiation Therapy Oncology Group June 2001 MeetingAdam P Dicker
The Lancet. Oncology|January 9, 2003
The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapyAdam P Dicker
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Predicting the future from trials of the past: epidermal growth factor receptor expression and outcome of fractionated radiation therapy trialsAdam P Dicker, Ulrich Rodeck
JMIR Medical Education|April 9, 2019
Telemedicine Training in Undergraduate Medical Education: Mixed-Methods ReviewShayan Waseh, Adam P Dicker
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Targeting the EGFR in neoplasia--more questions than answersAdam P Dicker, Ulrich Rodeck
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
CNS Metastases in Patients With Non-Small-Cell Lung Cancer and ALK Gene RearrangementWenyin Shi, Adam P Dicker
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity?Frank M Waterman, Adam P Dicker
International Journal of Radiation Oncology, Biology, Physics|January 16, 2003
Probability of late rectal morbidity in 125I prostate brachytherapyFrank M Waterman, Adam P Dicker
Future Oncology (London, England)|May 7, 2014
Radiation therapy and the immune system: learning to live togetherYaacov Richard Lawrence, Adam P Dicker
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?Frank M Waterman, Adam P Dicker
Pageof 29

Showing results (1-10 of 286) with videos related to

Sort By:
Pageof 29
American Journal of Clinical Oncology|August 7, 2003
COX-2 inhibitors and cancer therapeutics: potential roles for inhibitors of COX-2 in combination with cytotoxic therapy: reports from a symposium held in conjunction with the Radiation Therapy Oncology Group June 2001 MeetingAdam P Dicker
The Lancet. Oncology|January 9, 2003
The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapyAdam P Dicker
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Predicting the future from trials of the past: epidermal growth factor receptor expression and outcome of fractionated radiation therapy trialsAdam P Dicker, Ulrich Rodeck
JMIR Medical Education|April 9, 2019
Telemedicine Training in Undergraduate Medical Education: Mixed-Methods ReviewShayan Waseh, Adam P Dicker
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Targeting the EGFR in neoplasia--more questions than answersAdam P Dicker, Ulrich Rodeck
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
CNS Metastases in Patients With Non-Small-Cell Lung Cancer and ALK Gene RearrangementWenyin Shi, Adam P Dicker
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity?Frank M Waterman, Adam P Dicker
International Journal of Radiation Oncology, Biology, Physics|January 16, 2003
Probability of late rectal morbidity in 125I prostate brachytherapyFrank M Waterman, Adam P Dicker
Future Oncology (London, England)|May 7, 2014
Radiation therapy and the immune system: learning to live togetherYaacov Richard Lawrence, Adam P Dicker
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?Frank M Waterman, Adam P Dicker
Pageof 29